Immunotherapist
Immunotherapist
Senior member of the Denvax team
Dr Shalini Agrawal is a graduate and post graduate from the prestigious Armed Forces Medical College, Pune. She is also a Diploma in Minimal Access Surgery and in Hospital Administration.
She has worked as HOD and Senior Consultant in Maharaja Agrasen Hospital, Max Hospitals and Rockland Hospital. She was also a postgraduate teacher and many thesis and articles have been published under her guidance.
Member of the Denvax team
He has worked at reputed hospitals in and around Delhi NCR including PSRI, Narinder Mohan Hospital and Shanti Mukand Hospital.He is highly ambitious, competitive and is always looking for a new challenge, which led him to Dr Jamal A. Khan and Dr Sharmin Yaqin, who are pioneers of dendritic cell therapy for cancer treatment in India, Asia and the world.
Dr Rao has gained hands-on experience while working at Denvax and is more than equipped to handle and take care of cancer patients.
In his own words - "I think this is a unique and totally radical approach to treating cancers, offering a unique, safe and economical alternative option, which is, in general, prohibitively expensive. And this is the field and area of medicine that I want to explore, learn and apply to patients in need of treatment.
Member of the Denvax team
A Pain and Palliative Care Physician, he graduated from Pt. BDS PGIMS, Rohtak Haryana and then did his post-graduation in Rehabilitation Medicine from Safdarjung Hospital, New Delhi.
Thereafter he got trained in the field of Pain & palliative Care from Sir Ganga Ram Hospital, New Delhi or AIIMS, New Delhi. He has experience of working in reputed institutes of our country like Safdarjang Hospital New Delhi etc.
A kind, compassionate yet ambitious doctor, he is always looking for a new challenge, which led him to Dr Jamal A Khan and Dr Sharmin Yaqin, who are pioneers of dendritic cell therapy for cancer treatment in India, Asia and the world.
In his own words: During my working days in palliative care settings of various hospitals, I have seen cancer patients suffering from the disease itself or side effects of various anti-cancer treatments. Most patients were unable to take treatment due to various reasons. Dendritic Cell therapy is very simple & highly effective cancer treatment which can be given to patients who are amenable to conventional treatment approaches like surgery, chemotherapy or radiation. As it has negligible side effects, it is useful to terminally ill patients. It helps in maintaining the quality of life of such patients. I am dedicated to learning and applying this treatment approach so that maximum benefit could be given to each cancer patient.
Member of the Denvax team
An MBBS from SVS Medical College, Mahbubnagar, followed by a specialization in Radiation Oncology from the AJ Institute of Medical Sciences and Research, Dr. Rakesh Reddy Jillela has been a junior resident under Dr. Shekhar Patil in HCG Cancer Hospital Bangalore. He has also presented various papers and posters at national conferences, including the following three papers:
Equipped with a sound knowledge of medical terminology, he also has significant expertise in anti-cancer treatments and radiation cancer therapies. Besides, he is adept at handling OPD and treatment procedures such as intra cavitary, intraluminal ,surface mould brachytherapy IMRT and 3DCRT and electron beam therapy.
